On March 6, 2024, Perspective Therapeutics, Inc. closed the transaction. The company will issue securities pursuant to exemption provided under Regulation D from 9 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
76.02 USD | +0.16% | +0.65% | +22.61% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
76.02 USD | +0.16% | +0.65% | 5.27B | ||
1.75 USD | -2.78% | -3.31% | 1.03B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.61% | 5.27B | |
-1.29% | 12.64B | |
-0.47% | 8.46B | |
-2.03% | 4.49B | |
-53.56% | 3.11B | |
+19.30% | 2.87B | |
+33.07% | 2.31B | |
-8.42% | 2.23B | |
-3.55% | 1.89B | |
+5.37% | 1.64B |
- Stock Market
- Equities
- LNTH Stock
- News Lantheus Holdings, Inc.
- Perspective Therapeutics, Inc. announced that it has received $87.409482 million in funding from Lantheus Holdings, Inc. and other investors